This inventor holds 2 USPTO granted patents and 3 published patent applications and 1 EPO patent. Top assignees: Genzyme Corporation, Sionna Therapeutics Inc.. Active years: 2026.
Company Filing History:
2 out of 823 
2 out of 2 Years Active: 2026
Title: Franck Caussanel: Innovator in Pharmaceutical Compounds
Introduction
Franck Caussanel is a notable inventor based in Paris, France. He has made significant contributions to the field of pharmaceuticals, particularly in the development of macrocyclic compounds. With a total of 2 patents, his work has implications for various therapeutic applications.
Latest Patents
Caussanel's latest patents focus on macrocyclic compounds, compositions, and methods of using them. The disclosures include CFTR modulators, pharmaceutical compositions, and methods of making and utilizing these compounds. His innovative approach aims to enhance the efficacy of treatments in the pharmaceutical industry.
Career Highlights
Throughout his career, Franck Caussanel has worked with prominent companies such as Genzyme Corporation and Sionna Therapeutics Inc. His experience in these organizations has allowed him to refine his expertise in pharmaceutical research and development.
Collaborations
One of his notable collaborators is George Topalov. Their partnership has contributed to advancements in the field, showcasing the importance of teamwork in innovation.
Conclusion
Franck Caussanel's contributions to the pharmaceutical industry through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments.